Pfizer has decided to discontinue the manufacturing of Geocillin (carbenicillin indanyl sodium) 382mg tablets.
There are no other currently FDA approved manufacturers for carbenicillin tablets. Geocillin, a semisynthetic
penicillin, is indicated for the treatment of upper and lower urinary tract infections, asymptomatic bacteriuria,
and prostatitis due to susceptible strains.